The Obesity Epidemic and Its Impact on Hypertension

Canadian Journal of Cardiology

Volumn 28, Issue 3, 2012, Pages 326-333

  Nguyen, Thang ^a   Lau, David C W ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENCE; AEROBIC EXERCISE; ATHEROSCLEROSIS; BARIATRIC SURGERY; BODY WEIGHT; CARDIOVASCULAR DISEASE; DIETARY INTAKE; DISABILITY; DISEASE MODEL; ECONOMIC ASPECT; HEALTH BEHAVIOR; HUMAN; HYPERTENSION; MORBIDITY; MUSCULOSKELETAL DISEASE; NEOPLASM; NONHUMAN; OBESITY; PREVALENCE; REVIEW; RISK FACTOR; SODIUM RESTRICTION; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE AGENTS; ATTITUDE TO HEALTH; BARIATRIC SURGERY; BEHAVIOR THERAPY; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHILD; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; OBESITY, MORBID; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SEX DISTRIBUTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84860911096     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.01.001     Document Type: Review

References (68)

1. Lau D.C., Douketis J.D., Morrison K.M., et al. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ 2007, 176:S1-S13.
2. Global Health Risks: mortality and burden of disease attributable to selected major risks 2009 World Health Organization, Accessed November 12, 2011. http://www.who.int/healthinfo/global_burden_disease/global_health_risks/en/index.html.
3. Obesity and overweight. Fact sheet N°311 World Health Organization, Updated March 2011, Accessed November 15, 2011. http://www.who.int/mediacentre/factsheets/fs311/en/index.html.
4. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009, 373:1083-1096. Prospective Studies Collaboration.
5. Danaei G., Ding E.L., Mozaffarian D., et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009, 6:e1000058.
6. Stewart S.T., Cutler D.M., Rosen A.B. Forecasting the effects of obesity and smoking on U.S. life expectancy. New Engl J Med 2009, 361:2252-2260.
7. Garrison R.J., Kannel W.B., Stokes J., Castelli W.P. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987, 16:235-251.
8. Nguyen N.T., Magno C.P., Lane K.T., Hinojosa M.W., Lane J.S. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg 2008, 207:928-934.
9. Finucane M., Stevens G., Cowan M., et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet 2011, 377:557-567.
10. Patel R.B., Burke T.F. Urbanization - an emerging humanitarian disaster. New Engl J Med 2009, 361:741-743.
11. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303:235-241.
12. Wang Y.C., McPherson K., Marsh T., Gortmaker S.L., Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011, 378:815-825.
13. Bibbins-Domingo K., Coxson P., Pletcher M.J., Lightwood J., Goldman L. Adolescent overweight and future adult coronary heart disease. New Engl J Med 2007, 357:2371-2379.
14. Obesity in Canada 2011, Canadian Institute for Health Information and Public Health Agency of Canada, Ottawa.
15. Shields M., Tremblay M.S., Laviolette M., et al. Fitness of Canadian adults: results from the 2007-2009 Canadian Health Measures Survey. Health Rep 2010, 21:21-35.
16. Tremblay M.S., Shields M., Laviolette M., et al. Fitness of Canadian children and youth: results from the 2007-2009 Canadian Health Measures Survey. Health Rep 2010, 21:7-20.
17. Ogden C.L., Carroll M.D., Curtin L.R., Lamb M.M., Flegal K.M. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA 2010, 303:242-249.
18. Freedman D.S., Dietz W.H., Srinivasan S.R., Berenson G.S. Risk factors and adult body mass index among overweight children: the Bogalusa Heart Study. Pediatrics 2009, 123:750-757.
19. Baker J.L., Olsen L.W., Sørensen T.I.A. Childhood body mass index and the risk of coronary heart disease in adulthood. New Engl J Med 2007, 357:2329-2337.
20. Tirosh A., Shai I., Afek A., et al. Adolescent BMI trajectory and risk of diabetes versus coronary disease. New Engl J Med 2011, 364:1315-1325.
21. Daniels S.R., Arnett D.K., Eckel R.H., et al. Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation 2005, 111:1999-2012.
22. Juonala M., Magnussen C.G., Berenson G.S., et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. New Engl J Med 2011, 365:1876-1885.
23. Withrow D., Alter D.A. The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes Rev 2010, 12:131-141.
24. Birmingham C.L., Muller J.L., Palepu A., Spinelli J.J., Anis A.H. The cost of obesity in Canada. CMAJ 1999, 160:483-488.
25. Anis A.H., Zhang W., Bansback N., et al. Obesity and overweight in Canada: an updated cost-of-illness study. Obes Rev 2010, 11:31-40.
26. Field A.E., Coakley E.H., Must A., et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 2001, 161:1581-1586.
27. Brown C.D., Higgins M., Donato K.A., et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000, 8:605-619.
28. Maggio A.B., Aggoun Y., Marchand L.M., et al. Associations among obesity, blood pressure, and left ventricular mass. J Pediatr 2008, 152:489-493.
29. Salvadori M., Sontrop J.M., Garg A.X., et al. Elevated blood pressure in relation to overweight and obesity among children in a rural Canadian community. Pediatrics 2008, 122:e821-e827.
30. Lau D.C., Dhillon B., Yan H., Szmitko P.E., Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005, 288:H2031-H2041.
31. Lau D.C.W. Molecular biology of obesity. Obesity and Pregnancy 2008, 54-75. Royal Society of Medicine Press Ltd, London. M.C.P. Rees, M. Karoshi, L. Keith (Eds.).
32. Bełtowski J., Wǒjcicka G., Marciniak A., Jamroz A. Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension. Life Sci 2004, 74:2987-3000.
33. Canatan H., Bakan I., Akbulut M., et al. Comparative analysis of plasma leptin levels in both genders of patients with essential hypertension and healthy subjects. Endocr Res 2004, 30:95-105.
34. Shankar A., Xiao J. Positive relationship between plasma leptin level and hypertension. Hypertension 2010, 56:623-628.
35. Lau D.C., Yan H., Dhillon B. Metabolic syndrome: a marker of patients at high cardiovascular risk. Can J Cardiol 2006, 22(suppl B):85B-90B.
36. Leiter L.A., Fitchett D.H., Gilbert R.E., et al. Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol 2011, 27:e1-e33.
37. Dorresteijn J.A., Visseren F.L., Spiering W. Mechanisms linking obesity to hypertension. Obes Rev 2012, 13:17-26.
38. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. Arch Intern Med 1997, 157:657-667.
39. Goodpaster B.H., Delany J.P., Otto A.D., et al. Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA 2010, 304:1795-1802.
40. Neter J.E., Stam B.E., Kok F.J., Grobbee D.E., Geleijnse J.M. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003, 42:878-884.
41. Whelton S.P., Chin A., Xin X., He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002, 136:493-503.
42. Appel L.J., Brands M.W., Daniels S.R., et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 2006, 47:296-308.
43. Sacks F.M., Svetkey L.P., Vollmer W.M., et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet. New Engl J Med 2001, 344:3-10.
44. Bibbins-Domingo K., Chertow G.M., Coxson P.G., et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010, 362:590-599.
45. Rucker D., Padwal R., Li S.K., Curioni C., Lau D.C.W. An updated meta-analysis of long-term pharmacotherapy for obesity and overweight. Br Med J 2007, 335:1194-1199.
46. Torgerson J.S., Hauptman J., Boldrin M.N., Sjöström L. XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004, 27:155-161.
47. Siebenhofer A., Horvath K., Jeitler K., et al. Long-term effects of weight-reducing drugs in hypertensive patients. Cochrane Database Syst Rev 2009, CD007654.
48. Astrup A., Rössner S., Van G.L., et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 2009, 374:1606-1616.
49. Gadde K.M., Allison D.B., Ryan D.H., et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet 2011, 377:1341-1352.
50. Buchwald H., Avidor Y., Braunwald E., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004, 292:1724-1737.
51. Sjöström L., Lindroos A.K., Peltonen M., et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004, 351:2683-2693.
52. Sugerman H.J., Wolfe L.G., Sica D.A., Clore J.N. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003, 237:751-756.
53. Carson J.L., Ruddy M.E., Duff A.E., et al. The effect of gastric bypass surgery on hypertension in morbidly obese patients. Arch Intern Med 1994, 154:193-200.
54. Hinojosa M.W., Varela J.E., Smith B.R., Che F., Nguyen N.T. Resolution of systemic hypertension after laparoscopic gastric bypass. J Gastrointest Surg 2009, 13:793-797.
55. Pajecki D., Dalcanalle L., Souza de Oliveira C.P., et al. Follow-up of Roux-en-Y gastric bypass patients at 5 or more years postoperatively. Obes Surg 2007, 17:601-607.
56. Behrens C., Tang B.Q., Amson B.J. Early results of a Canadian laparoscopic sleeve gastrectomy experience. Can J Surg 2011, 54:138-143.
57. Benaiges D., Goday A., Ramon J.M., et al. Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up. Surg Obes Relat Dis 2011, 7:575-580.
58. Mohos E., Schmaldienst E., Prager M. Quality of life parameters, weight change and improvement of co-morbidities after laparoscopic Roux Y gastric bypass and laparoscopic gastric sleeve resection-comparative study. Obes Surg 2011, 21:288-294.
59. Sovik T.T., Aasheim E.T., Taha O., et al. Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial. Ann Intern Med 2011, 155:281-291.
60. Reinehr T., Kleber M., Toschke A.M. Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence. Atherosclerosis 2009, 207:174-180.
61. Rocchini A.P., Katch V., Schork A., Kelch R.P. Insulin and blood pressure during weight loss in obese adolescents. Hypertension 1987, 10:267-273.
62. Maahs D., de Serna D.G., Kolotkin R.L., et al. Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents. Endocr Pract 2006, 12:18-28.
63. Chanoine J.P., Hampl S., Jensen C., Boldrin M., Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA 2005, 293:2873-2883.
64. O'Brien P.E., Sawyer S.M., Laurie C., et al. Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA 2010, 303:519-526.
65. Collins J., Mattar S., Qureshi F., et al. Initial outcomes of laparoscopic Roux-en-Y gastric bypass in morbidly obese adolescents. Surg Obes Relat Dis 2007, 3:147-152.
66. Inge T.H., Miyano G., Bean J., et al. Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics 2009, 123:214-222.
67. Tobe S.W., Stone J.A., Brouwers M., et al. Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative. Can Med Assoc J 2011, 183:E1135-E1150.
68. Chockalingam A. Healthy weight - healthy blood pressure. Can J Cardiol 2010, 26:259-260.